RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.52 Billion CNY | -8.19% |
| 2022 | 6.02 Billion CNY | 44.77% |
| 2021 | 4.15 Billion CNY | 1.01% |
| 2020 | 4.11 Billion CNY | 497.36% |
| 2019 | 689.31 Million CNY | 29.79% |
| 2018 | 531.09 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 791.64 Million USD | 5.04% |
| 2024 Q3 | 813.39 Million USD | -0.73% |
| 2024 Q1 | 757.9 Million USD | -0.9% |
| 2023 Q3 | 754.83 Million USD | -87.06% |
| 2023 Q1 | 826.07 Million USD | -86.28% |
| 2023 FY | 5.52 Billion CNY | -8.19% |
| 2023 Q4 | 779.27 Million USD | 3.24% |
| 2023 Q2 | 5.83 Billion CNY | 605.88% |
| 2022 Q3 | 841.8 Million USD | -86.22% |
| 2022 Q2 | 6.1 Billion CNY | 510.97% |
| 2022 Q1 | 999.92 Million USD | -75.96% |
| 2022 FY | 6.02 Billion CNY | 44.77% |
| 2022 Q4 | 6.02 Billion CNY | 615.27% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 4.15 Billion CNY | 1.01% |
| 2021 Q4 | 4.15 Billion CNY | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 3.49 Billion CNY | 0.0% |
| 2020 FY | 4.11 Billion CNY | 497.36% |
| 2020 Q4 | 4.11 Billion CNY | 0.0% |
| 2020 Q2 | 1.08 Billion CNY | 0.0% |
| 2019 FY | 689.31 Million CNY | 29.79% |
| 2019 Q4 | 689.31 Million CNY | 0.0% |
| 2018 FY | 531.09 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | -14130.811% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -76470.987% |
| SQZ Biotechnologies Company | 107.18 Million USD | -5057.569% |
| Evofem Biosciences, Inc. | 10.55 Million USD | -52280.548% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | -4145.612% |
| Mesoblast Limited | 667.9 Million USD | -727.705% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -7639287.826% |
| Genus plc | 1.02 Billion USD | -437.296% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -406881.322% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -1107677.749% |
| Marizyme, Inc. | 22.01 Million USD | -25011.17% |
| ContraFect Corporation | 20.67 Million USD | -26633.609% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -881597.448% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -1416069.185% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -1446413.788% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -385941.862% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -133238.487% |
| MultiCell Technologies, Inc. | 126.22 USD | -4379846992.378% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -588205.599% |
| RVL Pharmaceuticals plc | 128.51 Million USD | -4201.8% |
| EV Biologics, Inc. | 431.71 Thousand USD | -1280433.64% |
| Q BioMed Inc. | 3.51 Million USD | -157152.632% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | -15614.611% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -717253.668% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -2115755.203% |
| Biomind Labs Inc. | 73.81 Thousand USD | -7488816.133% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 462.85 Million USD | -1094.382% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | -18318.297% |
| Skye Bioscience, Inc. | 11.94 Million USD | -46198.599% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -166764.563% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -201195.29% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -282214.067% |
| IMV Inc. | 31.33 Million USD | -17543.073% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -804024.448% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -212263.687% |
| GB Sciences, Inc. | 103.44 Thousand USD | -5344192.454% |
| Alpha Cognition Inc. | 2.45 Million USD | -225342.893% |
| HST Global, Inc. | 1526.00 USD | -362270083.486% |
| CSL Limited | 38.02 Billion USD | 85.46% |
| Halberd Corporation | 10.13 Thousand USD | -54567494.512% |
| Enzolytics Inc. | 361.7 Million USD | -1428.378% |
| Resverlogix Corp. | 8.11 Million USD | -68023.758% |
| Affymax, Inc. | 7.44 Million USD | -74174.392% |
| SYBLEU INC | 330.46 Thousand USD | -1672752.742% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -294287.448% |
| argenx SE | 4.54 Billion USD | -21.702% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | -19683.292% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | -11489.122% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -24266802.243% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -61673.91% |
| AVAX Technologies, Inc. | 7.37 Million USD | -74837.31% |
| Zenith Capital Corp. | 7410.00 USD | -74605068.691% |
| Genscript Biotech Corporation | 3.38 Billion USD | -63.249% |
| Ember Therapeutics, Inc. | 184.00 USD | -3004479791.304% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -1717780.649% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -2115050.901% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | -1138.658% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -381462.599% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 3.02 Million USD | -182646.639% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 52.7 Million USD | -10389.826% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -595640.877% |
| BioStem Technologies, Inc. | 14.56 Million USD | -37867.943% |
| ONE Bio Corp. | 70.08 Million USD | -7787.855% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -9682603.962% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -239317778.788% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -559457.455% |
| Agentix Corp. | 261.39 Thousand USD | -2114824.328% |
| LadRx Corporation | 2.3 Million USD | -239437.507% |
| Cell Source, Inc. | 195.17 Thousand USD | -2832412.515% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -1150282.369% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -1563241.977% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -1563241.977% |
| NovAccess Global Inc. | 62.24 Thousand USD | -8880896.98% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -864152.504% |
| Itoco Inc. | 1.4 Million USD | -394754.193% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -5779135.184% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -5215223.585% |
| Kadimastem Ltd | 2.3 Million USD | -239832.771% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -7240179.488% |
| CytoDyn Inc. | 11.13 Million USD | -49542.987% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -3866561.304% |
| Mobile Lads Corp. | 52.00 USD | -10631236438.462% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -30918485.011% |
| Qrons Inc. | 420.00 USD | -1316248233.333% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -1434052.764% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -1001175.628% |
| Rebus Holdings, Inc. | 5000.00 USD | -110564760.0% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -1350155.482% |
| International Stem Cell Corporation | 5.39 Million USD | -102464.805% |
| Bioxytran, Inc. | 137.63 Thousand USD | -4016409.249% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -36750.458% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -33244.852% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -6997675.949% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -639241.974% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -73443.209% |
| Neutra Corp. | 2851.00 USD | -193905301.613% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | -16959.319% |
| PureTech Health plc | 693.97 Million USD | -696.608% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -68394.388% |
| IXICO plc | 15.84 Million USD | -34791.927% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -66650.097% |
| Gelesis Holdings, Inc. | 103.32 Million USD | -5250.396% |
| CSL Limited | 38.02 Billion USD | 85.46% |
| Cellectis S.A. | 333.99 Million USD | -1555.189% |